印度Biocon Ltd 
凯朗·梅佐达·肖女士创办第一家印度生物技术公司Biocon．India．Ltd，如今，这家公司已经拥有900多名职工，她本人身兼公司主席和执行董事之职，这家公司目前仍是印度最大的生物技术公司之一。

"Our ability to continuously scale new heights across the biopharmaceutical value chain enables us to realise the promise of future therapeutics." -Kiran Mazumdar-Shaw, Chairman & Managing Director

Biocon is a fully integrated healthcare company that delivers innovative biopharmaceutical solutions. From discovery to development and commercialisation, we have the defining science, cost-effective drug development capabilities and significant manufacturing capacity to move ideas to market.

Leveraging India’s globally competitive cost base and exceptional scientific people resource, we are advancing our in-house R&D programs, while also providing custom and clinical research services to international pharmaceutical and biotechnology majors through our subsidiary companies, Syngene and Clinigene.

Biocon has rapidly developed a robust drug pipeline, led by monoclonal antibodies and several other molecules at exciting stages in the biopharmaceutical value chain. With the successful commercial launch of our first anti-cancer drug and several promising discovery partnerships in the clinic, we remain committed to scaling new heights in frontier science and achieving new milestones in affordable medicine.

The Innovation Matrix: A Strategic Framework